How it works
Targeting the most common allergic disease in children, Dermalaczyn® is a unique combination of patented probiotic strains specifically selected for the treatment of atopic dermatitis and for restoring the allergic immune system.
And it’s fortified with vitamin D to strengthen the normal function of the immune system and inflammatory response. Dermalaczyn® boasts a 50% reduction in allergy symptoms such as pruritus, sleep loss, redness and swelling, as well as a reduction in emotional stress.
An alternative therapy or taken in addition to corticosteroids, it is clinically tested with a high acceptance in children and is a pharmacy exclusive.
One randomized, placebo-controlled clinical trial (RCT) demonstrated significant reduction in clinical symptoms of atopic dermatitis in children. And 3 more RCTs demonstrated reduction in other allergy symptoms.
It has been shown to timulate the Th1 immune response (INF-γ) and reduces key mediators (IL-4 & IgE) of allergic response, while vitamin D helps alleviate symptoms of atopic dermatitis.
How to use
In lozenge form for children above the age of 3, or as a once-a-day sachet for children under the age of 3.
It can be taken as a standalone treatment, or in addition to emollient & topical corticosteroids, or other pharmacotherapy.
Dermalaczyn® is a registered trademark of Bluestone Pharma GmbH.